Ability to meet evolving requirements, including IDMP, ensures regulatory compliance for leading companies
Nottingham, England and Morrisville, NC – 2021 年 11 月 1 日 – Calyx, the eClinical and Regulatory solutions and services provider most relied on for solving complex data challenges in clinical research, today announced that two of the world’s Top 5 pharmaceutical companies have chosen to continue using the Calyx Regulatory Information Management (RIM) system for streamlining and optimizing their regulatory affairs processes. Based on their successful experiences and trust in Calyx RIM, the organizations have extended their contracts for up to five years.
Both organizations are relying on Calyx RIM to ensure compliance with increasingly complex global publishing requirements and for the management and tracking of detailed product information, registrations, and authorizations. In addition to complying with regulations enacted to ensure patient safety worldwide, these leading global pharmaceutical companies will leverage Calyx RIM to adhere to the Identification of Medicinal Products (IDMP) standard that will begin having an impact on European registrations in 2022.
“By choosing to extend their use of Calyx RIM, these leaders in the pharmaceutical industry have substantiated the true value Calyx RIM delivers,” said Jo English, Vice President, Regulatory Information Management, Calyx. “We’re honored to have earned their trust and to continue delivering the robust tools they need to comply with IDMP and other regulatory requirements, ultimately helping patients around the world maintain access to much-needed medical treatments.”
This marks three long-term Calyx RIM contract renewals signed by Top 10 Global Pharmaceutical companies in the past month.
Click here for more information on the benefits of Calyx RIM.
Through innovative eClinical and Regulatory solutions and services, Calyx turns the uncertain into the reliable, helping bring new medical treatments to market reliably. 凭借在临床开发方面的深厚专业知识以及在支持试验申办方和临床研究组织方面逾 25 年的经验，凯理斯利用其智慧和经验来解决复杂问题、提供快速见解并每天都将新药推向市场。
Christine Tobin | [电子邮件地址受保护] | +1 412-628-8598